View allAll Photos Tagged biosensors
The Dermal Abyss creates a direct access to the compartments in the body and reflects inner metabolic processes in the shape of a tattoo. Traditional tattoo inks are replaced with biosensors whose color changes in response to variations of glucose, pH and sodium in the interstitial fluid. It blends advances in biotechnology with traditional methods in tattoo artistry.
credit: Florian Voggeneder
Biosensor Protocols:
Biosensor research has shown that stimulating a puppy's neurological system from day 1 through 16 will change the puppy for the rest of it's life. Puppies exposed to specific types of stimulation have been found to have a greater tolerance of stress, faster adrenal systems, greater resistance to disease, and stronger heart beats. Other forms of tactile stimulation, such as stroking, have been found to lower blood pressure. This video shows some of the techniques found successful in the biosensor research.
Photos of Lab on a Chip Europe, Advances in Microarray Technology, Biodetection & Biosensors, Single Cell Analysis Europe, Barcelona 2013
Photo showing Xin Liu (CN) and theart piece The Dermal Abyss
It creates a direct access to the compartments in the body and reflects inner metabolic processes in the shape of a tattoo. Traditional tattoo inks are replaced with biosensors whose color changes in response to variations of glucose, pH and sodium in the interstitial fluid. It blends advances in biotechnology with traditional methods in tattoo artistry.
credit: Florian Voggeneder
From left to right; Mr. Matthew Connors, Director of Operations, Merlin MD; Mr. James Lim, Vice President/General Manager, Central Asia Pacific and Operations, Becton Dickinson and Company; Mr. Krish Gopalakrishnan (Panel Chair), Executive Council, Honorary Treasurer, BioSingapore; Dr Lim Chu Sing, Daniel, Associate Professor, School of Mechanical & Aerospace Engineering, Associate Professor, School of Chemical & Biomedical Engineering, Nanyang Technological University, Singapore; Ms Ang Gim Ching Jenny, Chair of the Medtech Manufacturing Initiative, Singapore Institute of Manufacturing Technology (SIMTech); Mr. Eric Loh Chee Mun, Senior Vice President, Biosensors International Group, Limited
Credits| Richard Yew
Photos of Lab on a Chip Europe, Advances in Microarray Technology, Biodetection & Biosensors, Single Cell Analysis Europe, Barcelona 2013
Son parte de la muestra productos ganadores de las categorías Producto Innovador como SensAr, un biosensor específico para contaminación por arsénico en agua de consumo; el motor-rueda eléctrico con controlador electrónico incorporado, para ser utilizado en bicicletas eléctricas, motos livianas o sillas de ruedas para discapacitados.
Photos of Lab on a Chip Europe, Advances in Microarray Technology, Biodetection & Biosensors, Single Cell Analysis Europe, Barcelona 2013
The Dermal Abyss creates a direct access to the compartments in the body and reflects inner metabolic processes in the shape of a tattoo. Traditional tattoo inks are replaced with biosensors whose color changes in response to variations of glucose, pH and sodium in the interstitial fluid. It blends advances in biotechnology with traditional methods in tattoo artistry.
credit: Florian Voggeneder
Photos of Lab on a Chip Europe, Advances in Microarray Technology, Biodetection & Biosensors, Single Cell Analysis Europe, Barcelona 2013
Enzymlogic provides binding kinetics expertise to a RETOS-COLABORACION project supported with €1.1 million funding from the Spanish Ministry of Economy and Competitiveness.
Enzymlogic is joining a group of leading Spanish academic and industry researchers known as the DIGITAL (Diagnostic, monitoring and treatment of patients with genetic disorders detected through newborn screening and metabolic rare diseases) consortium. The central aim of DIGITAL project is to promote a comprehensive, multi-faceted, yet mutually-reinforcing approach to developing better diagnostic methods, follow-up tests and treatments of inborn errors of metabolism (IEM) diseases.
What are IEMs?
IEMs are a genetically heterogeneous group of disorders characterized by dysfunction of an enzyme or other protein involved in cellular metabolism.
Although these diseases are individually rare, the total incidence has been shown to be upwards of 1/1000. IEMs are life-threatening and extremely-debilitating diseases which severely affect the pediatric population.
Enzymlogic will provide access to its expertise in enzymology and to its binding kinetics discovery platform to guide the affinity and kinetic optimization of drug candidates. In particular, Enzymlogic’s binding kinetics platform allow the study of how long drugs stay bound to their targets, helping researchers develop more effective treatments.
A public-private collaboration
The three-year program is grounded in a holistic view of innovation and seeks to develop a genetic method for diagnose IEMs detected through newborn screening, a state-of-the-art biosensor for monitoring diagnosed patients and novel therapeutic agents. We look forward to working with the other partners to advance our collective understanding in this area and to generate the tools needed to improve the success rate of drug discovery and development for the treatment of IEMs diseases.
The DIGITAL project has been set up as part of the RETOS-COLABORACION Program, and is funded with €1.1 million from the Spanish Ministry of Economy and Competitiveness. The project will include six partners from leading academic institutions (Barcelona University and Pompeu Fabra University) and biotech companies (Enzymlogic, qGenomics, Minorix and Devicare).
BioSentinel’s microfluidics card, designed at NASA Ames, will be used to study the impact of interplanetary space radiation on yeast. Once in orbit, the growth and metabolic activity of the yeast will be measured using a 3-color LED detection system and a metabolic indicator dye. Here, pink wells contain actively growing yeast cells that have turned the metabolic dye from blue to pink color.
Credit:NASA
The BioSentinel mission was selected in 2013 as one of three secondary payloads to fly on the Space Launch System's first Exploration Mission (EM-1) planned for launch in July 2018. The primary objective of BioSentinel is to develop a biosensor using a simple model organism to detect, measure, and correlate the impact of space radiation to living organisms over long durations beyond Low Earth Orbit (LEO). While progress identifying and characterizing biological radiation effects using Earth-based facilities has been significant, no terrestrial source duplicates the unique space radiation environment.
www.nasa.gov/centers/ames/engineering/projects/biosentine...
Bio Fluidic Antigen Van Der Pauw and/or Interdigital Capacitor Bio-Electronic Probe - USB Driven 16x16 Crosspoint Switch.
Engineers have developed a tiny, ultra-low power chip that could be injected just under the surface of the skin for continuous, long-term alcohol monitoring. The chip is powered wirelessly by a wearable device such as a smartwatch or patch. The goal of this work is to develop a convenient, routine monitoring device for patients in substance abuse treatment programs.
Press release: jacobsschool.ucsd.edu/news/news_releases/release.sfe?id=2521
Photo credit: David Baillot/UC San Diego Jacobs School of Engineering
Around 12% of the adult population suffer with Overactive Bladder (OAB), experiencing symptoms such as urinary urgency and incontinence, resulting in a significant decrease in quality of life.
The bladder is regulated by release of signalling molecules such as Acetylcholine (ACh), Adenosine Triphosphate (ATP), and Nitric Oxide (NO) from the inner lining of the bladder. Biosensors can be used to dynamically detect the changes in the concentration of these molecules directly in the urological environment.
This research evaluates different strategies for biosensor fabrication using glucose oxidase (GOx) as an example enzyme attached to an electrode so that glucose can be measured.
Photo showing Katia Vega (PE) and the art piece The Dermal Abyss.
It creates a direct access to the compartments in the body and reflects inner metabolic processes in the shape of a tattoo. Traditional tattoo inks are replaced with biosensors whose color changes in response to variations of glucose, pH and sodium in the interstitial fluid. It blends advances in biotechnology with traditional methods in tattoo artistry.
credit: Florian Voggeneder
“I sing the body electric” takes on new meaning in our brave new digital world, where devices let us monitor everything from our stress levels to our genetic sequences, and devices with 100 real-time biosensors loom on the horizon. Join moderator Arianna Huffington, @ariannahuff, as she leads Deepak Chopra, MD, @DeepakChopra, Founder of The Chopra Foundation and Chopra Center, Deepak Chopra LLC, David Daly, Head of Oncology, Life Technologies, @LIFECorporation, Andrew Thompson, President & CEO, Proteus Digital, @Proteusdh, Reed V. Tuckson, @DrReedTuckson, MD, FACP, Executive Vice President and Chief of Medical Affairs, UnitedHealth Group, @CEShealth, and Sonny Vu, Co-Founder & CEO, Misfit Wearables, @MisfitWearables, in conversation on the latest innovations in the field, how those innovations have the potential to change lives, and what the digital revolution means for the body, mind, and soul.
The Digital Health Summit at the 2013 International CES®
bit.ly/DigitalHealthCES - Focuses on the latest products and consumers' growing demand for high-tech health services. See solutions for diagnosing, monitoring and treating a variety of illnesses - from obesity to ADHD, from poor vision to high blood pressure.
Learn about games that reinforce healthy behaviors, body sensors that let people take more responsibility for their own health, affordable gene sequencing, real-time medicine monitoring, and more. You'll gain an understanding of the digital health infrastructure and how your organization can capitalize on this hot market.
Official Hashtag: #DigiHealthCES News & Press Articles: #DigiHealthCESPress CES Hashtag: #2013CES
Website: bit.ly/DigitalHealthWebsite
Twitter: bit.ly/DigitalHealthTwitter
YouTube Videos: bit.ly/DigitalHealthYouTube
Flickr Photos: bit.ly/DigitalHealthFlickr
Linkedin: bit.ly/DigitalHealthLinkedIn
Facebook: bit.ly/DigitalHealthFB
Google+: bit.ly/DigitalHealthGPlus
Pinterest: bit.ly/DigitalHealthPinterest
Instagram: bit.ly/DigitalHealthInstagram
Foursquare: bit.ly/DigitalHealthFourSquare
Thank you! AARP bit.ly/AARP_DHS for sponsoring Digital Health Summit Live.
Social Media Team: www.newmediasynergy.com
Photos by Asa Mathat www.asamathat.com